作者
S Ikematsu, A Yano, K Aridome, M Kikuchi, H Kumai, H Nagano, K Okamoto, M Oda, S Sakuma, T Aikou, H Muramatsu, K Kadomatsu, T Muramatsu
发表日期
2000/9
期刊
British journal of cancer
卷号
83
期号
6
页码范围
701-706
出版商
Nature Publishing Group
简介
The level of expression of midkine (MK), a heparin-binding growth factor, is increased in many types of human carcinomas. An enzyme-linked immunoassay, which utilizes a combination of rabbit and chicken antibodies revealed that serum MK level in the controls (n= 135) was 0.154±0.076 (mean±SD) ng ml–1 with an apparent cut-off value as 0.5 ng ml–1. Serum MK level was significantly elevated in the cancer patients (n= 150)(P< 0.001); 87% of the patients showed levels of more than 0.5 ng ml–1. All ten types of cancer examined showed a similar profile of serum MK level. There was no or weak correlation between C-reactive protein level, a marker of inflammation, and serum MK level. Furthermore, in case of gastric carcinoma and lung carcinoma, patients with stage I carcinoma already showed elevated serum MK levels. The present results indicated that serum MK could serve as a general tumour marker with …
引用总数
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242107121718222025211920221081413106978472
学术搜索中的文章
S Ikematsu, A Yano, K Aridome, M Kikuchi, H Kumai… - British journal of cancer, 2000